Related Experiment Videos
Opportunities for cardiovascular risk reduction with angiotensin II receptor blockers
1University of Maryland Hospital, Renal Division, N3W 143, Baltimore, MD 21202, USA. mweir@medicine.umaryland.edu
Current Hypertension Reports
|September 10, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Eplerenone Revisited: A Balanced Reappraisal of Its Role in Hypertension, Heart Failure, and Cardiorenal Disease.
Journal of cardiovascular pharmacology·2026
Elevations in Donor-Derived Cell-Free DNA and Allograft Outcomes in Kidney Transplantation.
Journal of the American Society of Nephrology : JASN·2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.
Hypertension (Dallas, Tex. : 1979)·2026
Indigenous Health Disparities in Hypertensive Disorders of Pregnancy Within the United States.
Current hypertension reports·2026
The Cardio-Renal-Hepatic Axis in MASLD. Role of BDNF, NGF, and Metabolic Cross-Talk.
Current hypertension reports·2026
Occupational Physical Activity and Hypertension: A Narrative Review.
Current hypertension reports·2026
Parental Obesity and Offspring Risk for Cardiorenal Diseases.
Current hypertension reports·2026
MASLD and Cardiovascular Risk: Mechanisms and Implications for Clinical Practice.
Current hypertension reports·2026
Toward Precision Aspirin Prophylaxis: Optimal Aspirin Dosing For Prevention of Preeclampsia.
Current hypertension reports·2026
Insights into antifungal mechanism of cumin aldehyde against Magnaporthe oryzae.
Pest management science·2026
A Pathogen-Hopping Approach for the Identification of Compounds with Multistage Antischistosomal Activity.
ACS infectious diseases·2026
Total Synthesis of Paenitracin B and Analogues with Enhanced Antibacterial Activity.
ACS infectious diseases·2026